Teva nears settlement in US antitrust case over QVAR
MLex Summary: Teva Pharmaceuticals notified a US federal judge that it has reached a settlement in principle with plaintiffs accusing it of illegally delaying generic competition for QVAR, a line of...To view the full article, register now.
Already a subscriber? Click here to view full article